Skip to main content
. 2016 Apr 15;7(24):35979–35988. doi: 10.18632/oncotarget.8745

Table 1. Clinicopathological features of SQCCs in never-smokers.

Value Frequency Percentage
Gender
  Male 51 58.0%
  Female 37 42.0%
Age
  < 55 21 23.9%
  ≥ 55 67 76.1%
  Mean (years) ± SD 61.39 ± 10.40
Personal History of Malignant Tumor
  Yes 8 9.1%
  No 80 90.9%
Family History of Malignant Tumor
  Yes 9 10.2%
  No 79 89.8%
Locations of tumor
  peripheral 34 38.6%
  central 54 61.4%
N-stage
  0 45 51.1%
  1 16 18.2%
  2 26 29.5%
  3 1 1.1%
Differentiated Degree
  well & moderate 25 28.4%
  poor 62 70.5%
  unknown & 1 1.1%
Maximum length of tumor
  < 3 15 17.0%
  ≥ 3 70 79.6%
  unavailable! 3 3.4%
  Mean (cm) ± SD 4.43 ± 2.28
Methods of surgery
  pneumonectomy 9 10.2%
  lobectomy* 75 85.2%
  others^ 4 4.5%
Pathological stage
  I 34 38.6%
  II 20 22.7%
  III 31 35.2%
  IV 3 3.4%
oncogenic mutations
  present’ 16 18.2%
  absent 60 68.2%
  unknown 12 13.6%

SD: standard deviation;

&

definite degree of differentiation was not determined for 1 patient.

!

could not be determined from the final pathological reports.

*

including 7 patients who received sleeve resection.

^

3 patients received wedge resection, 1 patient received sublobar resection.

§ including EGFR, KRAS, HER2, BRAF, AKT1, PIK3CA and FGFR.